EPISODE · Aug 5, 2025 · 38 MIN
More than a Cure Part 2: Q&A With an Oncologist Answering Your Toughest Cancer Questions
from The Cancer Project · host Oklahoma Proton Center
Dr. John Chang is the esteemed Medical Director of the Oklahoma Proton Center, recognized as one of the top radiation oncologists in the United States. With a robust career background that includes significant tenures in Chicago at Northwestern Memorial Hospital and Vanderbilt University, Dr. Chang has spearheaded advancements in proton therapy for cancer treatment. Highly committed to both his field and his athletic pursuits, Dr. Chang is devoted to improving cancer care through innovative therapies while maintaining a deep commitment to enhancing patients' quality of life.Stay informed and empowered as we explore the intersection of technology and medicine. Tune in for thought-provoking discussions, expert interviews, and practical advice to help you or your loved ones on the journey through cancer treatment and recovery.
What this episode covers
Dr. John Chang is the esteemed Medical Director of the Oklahoma Proton Center, recognized as one of the top radiation oncologists in the United States. With a robust career background that includes significant tenures in Chicago at Northwestern Memorial Hospital and Vanderbilt University, Dr. Chang has spearheaded advancements in proton therapy for cancer treatment. Highly committed to both his field and his athletic pursuits, Dr. Chang is devoted to improving cancer care through innovative therapies while maintaining a deep commitment to enhancing patients' quality of life.Stay informed and empowered as we explore the intersection of technology and medicine. Tune in for thought-provoking discussions, expert interviews, and practical advice to help you or your loved ones on the journey through cancer treatment and recovery.
NOW PLAYING
More than a Cure Part 2: Q&A With an Oncologist Answering Your Toughest Cancer Questions
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m